Stocks · Korea 251120 KOSDAQ

Bio-fd&c

9,910원 -0.90% Market cap 862억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 6 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER12.67x

PBR1.21x

EPS782 KRW

BPS8,184 KRW

ROE8.73%

Dividend yield0.00%

DPS0 KRW

Payout ratio0.00%

Returns and 52-week range

1W+2.32%

1M+9.58%

3M+13.02%

6M-29.97%

1Y-46.18%

YTD-38.87%

52W high18,490원

52W low6,330원

From 52W high-47.43%

Financial results (separate)

Period	Revenue	Operating income	Net income	OP margin
2022	159억	49억	43억	30.8%
2023	156억	50억	56억	32.3%
2024	161억	49억	45억	30.2%
2025	192억	63억	67억	32.6%
Quarterly
2024 4Q	47억	16억	18억	33.6%
2025 1Q	43억	14억	16억	33.3%
2025 2Q	47억	18억	18억	39.4%
2025 3Q	51억	17억	19억	33.4%
2025 4Q	51억	13억	13억	25.0%
2026 1Q	40억	10억	12억	25.7%

Company

CEO모상현, 정대현

Founded2005-11-11

Fiscal year end12

Websitewww.biofdnc.com

Address: 인천광역시 연수구 송도미래로 30 A동 509호, 510호, 511호

Peers in the same sector

Company	Market cap	P/E	P/B	1M
동국생명과학	880억	10.00	0.67	+20.35%
중앙백신	853억	14.04	0.81	-0.86%
삼아제약	891억	6.60	0.37	+0.29%
대봉엘에스	845억	8.29	0.59	-4.51%
국제약품	937억	15.82	0.96	+30.87%
테라젠이텍스	842억	7.65	0.60	+8.96%

Recent filings

2026-08-14반기보고서 (2026.06)
2026-05-13분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.